Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wonderling

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Heart (British Cardiac Society)|December 14, 2012
Cost-effectiveness analysis of serial measurement of circulating natriuretic peptide concentration in chronic heart failurePhilippe Laramée, David Wonderling, Sharon Swain, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility AnalysisDalia Dawoud, Elisabetta Fenu, Bernard Higgins, et al.
The Cochrane Database of Systematic Reviews|June 8, 2013
Nutritional screening for improving professional practice for patient outcomes in hospital and primary care settingsAmir-Houshang Omidvari, Yasaman Vali, Susan M Murray, et al.
Journal of Public Health Medicine|April 3, 2003
Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screeningDalya Marks, Margaret Thorogood, H Andrew W Neil, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-AnalysisDalia Dawoud, Rachel O'Mahony, David Wonderling, et al.
BMJ (Clinical Research Ed.)|March 28, 2024
Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidanceDavid Wonderling, Alfredo Mariani, Eleanor J Samarasekera, et al.
BMJ (Clinical Research Ed.)|June 1, 2002
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemiaDalya Marks, David Wonderling, Margaret Thorogood, et al.
Pharmacoeconomics|December 21, 2014
Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysisLaura M Sawyer, David Wonderling, Karina Jackson, et al.
Pharmacoeconomics|June 11, 2019
Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic ReviewDalia M Dawoud, Alexander Haines, David Wonderling, et al.
Seminars in Vascular Medicine|June 17, 2004
Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The NetherlandsDavid Wonderling, Marina A W Umans-Eckenhausen, Dalya Marks, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Heart (British Cardiac Society)|December 14, 2012
Cost-effectiveness analysis of serial measurement of circulating natriuretic peptide concentration in chronic heart failurePhilippe Laramée, David Wonderling, Sharon Swain, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility AnalysisDalia Dawoud, Elisabetta Fenu, Bernard Higgins, et al.
The Cochrane Database of Systematic Reviews|June 8, 2013
Nutritional screening for improving professional practice for patient outcomes in hospital and primary care settingsAmir-Houshang Omidvari, Yasaman Vali, Susan M Murray, et al.
Journal of Public Health Medicine|April 3, 2003
Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screeningDalya Marks, Margaret Thorogood, H Andrew W Neil, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-AnalysisDalia Dawoud, Rachel O'Mahony, David Wonderling, et al.
BMJ (Clinical Research Ed.)|March 28, 2024
Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidanceDavid Wonderling, Alfredo Mariani, Eleanor J Samarasekera, et al.
BMJ (Clinical Research Ed.)|June 1, 2002
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemiaDalya Marks, David Wonderling, Margaret Thorogood, et al.
Pharmacoeconomics|December 21, 2014
Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysisLaura M Sawyer, David Wonderling, Karina Jackson, et al.
Pharmacoeconomics|June 11, 2019
Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic ReviewDalia M Dawoud, Alexander Haines, David Wonderling, et al.
Seminars in Vascular Medicine|June 17, 2004
Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The NetherlandsDavid Wonderling, Marina A W Umans-Eckenhausen, Dalya Marks, et al.
Pageof 4